Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Cardiac Dysfunction in Patients Treated With Trastuzumab for HER-2 Positive Breast Cancer. The CADY Study

NCT00968682 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT00968682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00968682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Cardiac Dysfunction in Patients Treated With Trastuzumab for HER-2 Positive Breast Cancer. The CADY Study
Lead sponsor
Cancer Trials Ireland
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
Not reported
Enrollment
480 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiac toxicity